<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — April 2022]]></title><description><![CDATA[<p dir="auto">Novo/Sydbank: Nyt prisloft rammer næppe producenterne <a href="https://proinvestor.com/investornyt/803380/novo-sydbank-nyt-prisloft-rammer-naeppe-producenterne" rel="nofollow ugc">https://proinvestor.com/investornyt/803380/novo-sydbank-nyt-prisloft-rammer-naeppe-producenterne</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400284/novo-april-2022</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 21:03:46 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400284.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 01 Apr 2022 05:36:43 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 12:32:56 GMT]]></title><description><![CDATA[<p dir="auto">bedste aktie i min beholdning samme med apple</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978120</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978120</guid><dc:creator><![CDATA[Riis7]]></dc:creator><pubDate>Fri, 29 Apr 2022 12:32:56 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 09:41:27 GMT]]></title><description><![CDATA[<p dir="auto">Novo/CEO: Kolossal vækst i GLP-1 kunne potentielt være større - NY <a href="https://www.proinvestor.com/investornyt/816098/novo-ceo-kolossal-vaekst-i-glp-1-kunne-potentielt-vaere-storre-ny" rel="nofollow ugc">https://www.proinvestor.com/investornyt/816098/novo-ceo-kolossal-vaekst-i-glp-1-kunne-potentielt-vaere-storre-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978123</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978123</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 29 Apr 2022 09:41:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 06:36:36 GMT]]></title><description><![CDATA[<p dir="auto">Vildt regnskab fra Novo:<br />
<a href="https://www.proinvestor.com/boards/103162" rel="nofollow ugc">https://www.proinvestor.com/boards/103162</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978122</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978122</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 29 Apr 2022 06:36:36 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 06:28:22 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Sydbank: Stærkt momentum sikrer rendyrket opjustering <a href="https://www.proinvestor.com/investornyt/816023/novo-sydbank-staerkt-momentum-sikrer-rendyrket-opjustering" rel="nofollow ugc">https://www.proinvestor.com/investornyt/816023/novo-sydbank-staerkt-momentum-sikrer-rendyrket-opjustering</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978118</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978118</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 29 Apr 2022 06:28:22 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 06:23:27 GMT]]></title><description><![CDATA[<p dir="auto">Novo Q1: GLP-1-analoger trækker klart positiv overraskelse <a href="https://www.proinvestor.com/investornyt/816025/novo-q1-glp-1-analoger-traekker-klart-positiv-overraskelse-ny3" rel="nofollow ugc">https://www.proinvestor.com/investornyt/816025/novo-q1-glp-1-analoger-traekker-klart-positiv-overraskelse-ny3</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978124</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978124</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 29 Apr 2022 06:23:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 06:20:44 GMT]]></title><description><![CDATA[<p dir="auto">Novo Q1: Vækst og opjustering drevet af Ozempic - NY <a href="https://www.proinvestor.com/investornyt/816026/novo-q1-vaekst-og-opjustering-drevet-af-ozempic-ny" rel="nofollow ugc">https://www.proinvestor.com/investornyt/816026/novo-q1-vaekst-og-opjustering-drevet-af-ozempic-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978119</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978119</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 29 Apr 2022 06:20:44 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 05:51:24 GMT]]></title><description><![CDATA[<p dir="auto">En lille historie fra det nordjyske. Novo skulle bruge 40 medarbejdere i 1 år til 3 holdskift på fabrikken i Hjørring. Der kom 445 ansøgninger.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978115</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978115</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Fri, 29 Apr 2022 05:51:24 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 05:47:51 GMT]]></title><description><![CDATA[<p dir="auto">Fremragende firma...:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978121</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978121</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Fri, 29 Apr 2022 05:47:51 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 05:36:42 GMT]]></title><description><![CDATA[<p dir="auto">Aktier/åbning: Novo brager op efter fremragende kvartal og opjustering <a href="https://proinvestor.com/investornyt/816018/aktier-abning-novo-brager-op-efter-fremragende-kvartal-og-opjustering" rel="nofollow ugc">https://proinvestor.com/investornyt/816018/aktier-abning-novo-brager-op-efter-fremragende-kvartal-og-opjustering</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978117</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978117</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 29 Apr 2022 05:36:42 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Fri, 29 Apr 2022 05:01:14 GMT]]></title><description><![CDATA[<p dir="auto">her går det godt <a href="https://borsen.dk/nyheder/virksomheder/novo-nordisk-opjusterer-efter-salgsfremgang-paa-24-pct?b_source=borsen&amp;b_medium=row_1&amp;b_campaign=list_2https://borsen.dk/nyheder/virksomheder/novo-nordisk-opjusterer-efter-salgsfremgang-paa-24-pct?b_source=borsen&amp;b_medium=row_1&amp;b_campaign=list_2" rel="nofollow ugc">https://borsen.dk/nyheder/virksomheder/novo-nordisk-opjusterer-efter-salgsfremgang-paa-24-pct?b_source=borsen&amp;b_medium=row_1&amp;b_campaign=list_2https://borsen.dk/nyheder/virksomheder/novo-nordisk-opjusterer-efter-salgsfremgang-paa-24-pct?b_source=borsen&amp;b_medium=row_1&amp;b_campaign=list_2</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978112</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978112</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Fri, 29 Apr 2022 05:01:14 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 28 Apr 2022 13:48:47 GMT]]></title><description><![CDATA[<p dir="auto">Novo: Fase 3-data fra ugentligt insulin har nået endemål <a href="https://www.proinvestor.com/investornyt/815503/novo-fase-3-data-fra-ugentligt-insulin-har-naet-endemal-ny" rel="nofollow ugc">https://www.proinvestor.com/investornyt/815503/novo-fase-3-data-fra-ugentligt-insulin-har-naet-endemal-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978116</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978116</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 28 Apr 2022 13:48:47 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 28 Apr 2022 10:20:54 GMT]]></title><description><![CDATA[<p dir="auto">Novo-rival viser lovende data med Wegovy-konkurrent<br />
<a href="https://www.proinvestor.com/investornyt/815223/novo-rival-viser-lovende-data-med-wegovy-konkurrent" rel="nofollow ugc">https://www.proinvestor.com/investornyt/815223/novo-rival-viser-lovende-data-med-wegovy-konkurrent</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978110</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978110</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 28 Apr 2022 10:20:54 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Mon, 25 Apr 2022 07:31:07 GMT]]></title><description><![CDATA[<p dir="auto">højere omkostninger mener en analytiker: <a href="https://borsen.dk/nyheder/virksomheder/analysehus-inflation-koster-milliarder-for-novo-nordisk?utm_source=borsen&amp;utm_medium=row_1&amp;utm_campaign=news_1" rel="nofollow ugc">https://borsen.dk/nyheder/virksomheder/analysehus-inflation-koster-milliarder-for-novo-nordisk?utm_source=borsen&amp;utm_medium=row_1&amp;utm_campaign=news_1</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978113</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978113</guid><dc:creator><![CDATA[koden]]></dc:creator><pubDate>Mon, 25 Apr 2022 07:31:07 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Mon, 25 Apr 2022 03:48:00 GMT]]></title><description><![CDATA[<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://medicaldialogues.in/news/industry/pharma/novo-nordisk-bags-cdsco-panel-nod-to-study-anti-neoplastic-drug-concizumab-91911" title="Novo Nordisk Get's CDSCO Nod to conduct Phase IIIa clinical trial of Anti-Neoplastic Concizumab">
<img src="https://medicaldialogues.in/h-upload/2022/04/19/174592-img-20220419-wa0015.jpg" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://medicaldialogues.in/news/industry/pharma/novo-nordisk-bags-cdsco-panel-nod-to-study-anti-neoplastic-drug-concizumab-91911">
Novo Nordisk Get's CDSCO Nod to conduct Phase IIIa clinical trial of Anti-Neoplastic Concizumab
</a>
</h5>
<p class="card-text line-clamp-3">New Delhi: In line with the drug major Novo-Nordisk's proposal for Phase IIIa clinical trial of antineoplastic drug Concizumab, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...</p>
</div>
<a href="https://medicaldialogues.in/news/industry/pharma/novo-nordisk-bags-cdsco-panel-nod-to-study-anti-neoplastic-drug-concizumab-91911" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://medicaldialogues.in/images/ico/favicon.ico?v=1" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>





<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(medicaldialogues.in)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978111</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978111</guid><dc:creator><![CDATA[bibob]]></dc:creator><pubDate>Mon, 25 Apr 2022 03:48:00 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Mon, 25 Apr 2022 03:47:51 GMT]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978109</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978109</guid><dc:creator><![CDATA[bibob]]></dc:creator><pubDate>Mon, 25 Apr 2022 03:47:51 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Mon, 25 Apr 2022 03:46:09 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Cowen: Anbefalingen og kursmål sendes i vejret <a href="https://proinvestor.com/investornyt/812835/novo-cowen-anbefalingen-og-kursmal-sendes-i-vejret" rel="nofollow ugc">https://proinvestor.com/investornyt/812835/novo-cowen-anbefalingen-og-kursmal-sendes-i-vejret</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978105</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978105</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 25 Apr 2022 03:46:09 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 21 Apr 2022 04:49:58 GMT]]></title><description><![CDATA[<p dir="auto">Aktier/tendens: Kursmålsændringer til Mærsk, Novo og Carlsberg <a href="https://proinvestor.com/investornyt/811268/aktier-tendens-kursmalsaendringer-til-maersk-novo-og-carlsberg" rel="nofollow ugc">https://proinvestor.com/investornyt/811268/aktier-tendens-kursmalsaendringer-til-maersk-novo-og-carlsberg</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978108</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978108</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 21 Apr 2022 04:49:58 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 21 Apr 2022 04:08:50 GMT]]></title><description><![CDATA[<p dir="auto">Bernstein: Ændrer kursmål for tre store danske medicinalvirksomheder <a href="https://proinvestor.com/investornyt/811262/bernstein-aendrer-kursmal-for-tre-store-danske-medicinalvirksomheder" rel="nofollow ugc">https://proinvestor.com/investornyt/811262/bernstein-aendrer-kursmal-for-tre-store-danske-medicinalvirksomheder</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978114</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978114</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 21 Apr 2022 04:08:50 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Tue, 19 Apr 2022 04:51:30 GMT]]></title><description><![CDATA[<p dir="auto">Aktier/tendens: Novo og Mærsk i rampelyset før lyserød genstart <a href="https://proinvestor.com/investornyt/810015/aktier-tendens-novo-og-maersk-i-rampelyset-for-lyserod-genstart" rel="nofollow ugc">https://proinvestor.com/investornyt/810015/aktier-tendens-novo-og-maersk-i-rampelyset-for-lyserod-genstart</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978103</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978103</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 19 Apr 2022 04:51:30 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Tue, 19 Apr 2022 03:54:00 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk får løftet kursmål af fem finanshuse <a href="https://proinvestor.com/investornyt/810006/novo-nordisk-far-loftet-kursmal-af-fem-finanshuse" rel="nofollow ugc">https://proinvestor.com/investornyt/810006/novo-nordisk-far-loftet-kursmal-af-fem-finanshuse</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978100</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978100</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 19 Apr 2022 03:54:00 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Tue, 12 Apr 2022 03:06:28 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Morgan Stanley: Hæver anbefaling til "ligevægt" fra "undervægt" <a href="https://proinvestor.com/investornyt/807628/novo-morgan-stanley-haever-anbefaling-til-ligevaegt-fra-undervaegt" rel="nofollow ugc">https://proinvestor.com/investornyt/807628/novo-morgan-stanley-haever-anbefaling-til-ligevaegt-fra-undervaegt</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978097</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978097</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 12 Apr 2022 03:06:28 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 07 Apr 2022 13:11:53 GMT]]></title><description><![CDATA[<p dir="auto">Som jeg siger til min datter, der er ansat og løbende har fået medarbejderaktier: behold dem...kurs 1000 nærmer sig;-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978099</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978099</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Thu, 07 Apr 2022 13:11:53 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 07 Apr 2022 13:09:08 GMT]]></title><description><![CDATA[<p dir="auto">Der er nogen der vil ind:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978102</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978102</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Thu, 07 Apr 2022 13:09:08 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — April 2022 on Thu, 07 Apr 2022 13:08:35 GMT]]></title><description><![CDATA[<p dir="auto">Heftig oms i dag 3,3 mia.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978101</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978101</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Thu, 07 Apr 2022 13:08:35 GMT</pubDate></item></channel></rss>